S-Benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase

被引:40
作者
Matsuno, Kenji [1 ]
Takai, Kazushige [1 ]
Isaka, Yoshinobu [1 ]
Unno, Yuka [1 ]
Sato, Masayuki [1 ]
Takikawa, Osamu [2 ]
Asai, Akira [1 ]
机构
[1] Univ Shizuoka, Grad Sch Pharmaceut Sci, Suruga Ku, Shizuoka 4228526, Japan
[2] Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Aichi 4748522, Japan
关键词
SAR; IDO; Tryptophan; Kynurenine; Cancer; HUMAN INDOLEAMINE 2,3-DIOXYGENASE; COMPETITIVE INHIBITORS; TRYPTOPHAN-METABOLISM; BINDING; CELLS; DIOXYGENASE; EXPRESSION; TOLERANCE; MECHANISM; CANCER;
D O I
10.1016/j.bmcl.2010.07.025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
S-Benzylisothiourea 3a was discovered by its ability to inhibit indoleamine-2,3-dioxygenase (IDO) in our screening program. Subsequent optimization of the initial hit 3a lead to the identification of sub-mu M inhibitors 3r and 10h, both of which suppressed kynurenine production in A431 cells. Synthesis and structure-activity relationship of S-benzylisothiourea analogues as small-molecule inhibitors of IDO are described. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5126 / 5129
页数:4
相关论文
共 27 条
[1]   Chemistry and neurochemistry of the kynurenine pathway of tryptophan metabolism [J].
Botting, NP .
CHEMICAL SOCIETY REVIEWS, 1995, 24 (06) :401-&
[2]   Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer:: Effect on tumor-infiltrating T cells [J].
Brandacher, G ;
Perathoner, A ;
Ladurner, R ;
Schneeberger, S ;
Obrist, P ;
Winkler, C ;
Werner, ER ;
Werner-Felmayer, G ;
Weiss, HG ;
Göbel, G ;
Margreiter, R ;
Königsrainer, A ;
Fuchs, D ;
Amberger, A .
CLINICAL CANCER RESEARCH, 2006, 12 (04) :1144-1151
[3]   1-METHYL-DL-TRYPTOPHAN, BETA-(3-BENZOFURANYL)-DL-ALANINE (THE OXYGEN ANALOG OF TRYPTOPHAN), AND BETA-[3-BENZO(B)THIENYL]-DL-ALANINE (THE SULFUR ANALOG OF TRYPTOPHAN) ARE COMPETITIVE INHIBITORS FOR INDOLEAMINE 2,3-DIOXYGENASE [J].
CADY, SG ;
SONO, M .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 291 (02) :326-333
[4]   Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A [J].
Carr, Gavin ;
Chung, Marco K. W. ;
Mauk, A. Grant ;
Andersen, Raymond J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (09) :2634-2637
[5]  
Fujigaki H., 2007, INT CONGR SER, V1304, P314
[6]   Structure-activity study of Brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors [J].
Gaspari, P ;
Banerjee, T ;
Malachowski, WP ;
Muller, AJ ;
Prendergast, GC ;
DuHadaway, J ;
Bennett, S ;
Donovan, AM .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (02) :684-692
[7]   Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus [J].
Guillemin, GJ ;
Brew, BJ ;
Noonan, CE ;
Takikawa, O ;
Cullen, KM .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2005, 31 (04) :395-404
[8]   Ligand efficiency: a useful metric for lead selection [J].
Hopkins, AL ;
Groom, CR ;
Alex, A .
DRUG DISCOVERY TODAY, 2004, 9 (10) :430-431
[9]   Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses [J].
Hou, De-Yan ;
Muller, Alexander J. ;
Sharma, Madhav D. ;
DuHadaway, James ;
Banerjee, Tinku ;
Johnson, Maribeth ;
Mellor, Andrew L. ;
Prendergasts, George C. ;
Munn, David H. .
CANCER RESEARCH, 2007, 67 (02) :792-801
[10]   Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase [J].
Kumar, Sanjeev ;
Jaller, Daniel ;
Patel, Bhumika ;
LaLonde, Judith M. ;
DuHadaway, James B. ;
Malachowski, William P. ;
Prendergast, George C. ;
Muller, Alexander J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (16) :4968-4977